In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits

International Journal of Food Microbiology

Volumn 144, Issue 3, 2011, Pages 393-399

  De Llanos, R ^a   Llopis, S ^a   Molero, G ^b   Querol, A ^a   Gil, C ^b   Fernandez Espinar M T ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Baker's strain; Clinical strains; In vivo virulence; Industrial strains; S. cerevisiae; S. cerevisiae var. boulardii

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MOUSE; MYCOSIS; NONHUMAN; PHENOTYPE; SACCHAROMYCES CEREVISIAE; YEAST; YEAST CELL;

ANIMALS; FEMALE; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PHENOTYPE; SACCHAROMYCES CEREVISIAE; VIRULENCE;

MURINAE; MUS; SACCHAROMYCES CEREVISIAE;

EID: 78649997889     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.10.025     Document Type: Article

References (42)

1. Bistoni F., Vecchiarelli A., Cenci E., Sbaraglia G., Perito S., Cassone A. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. Sabouraudia 1984, 22:409-418.
2. Byron J.K., Clemons K.V., McCusker J.H., Davis R.W., Stevens D.A. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice. Infection and Immunity 1995, 63:478-485.
3. Carle G.F., Olson M.W. An electrophoretic karyotype for yeast. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:3756-3760.
4. Clemons K.V., McCusker J.H., Davis R.W., Stevens D.A. Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. The Journal of Infectious Diseases 1994, 169:859-867.
5. Clemons, K.V., Salonen, J.H., Issakainen, J., Nikoskelainen, J., McCullough, M.J., Jorge, J.J., Stevens, D.A., 2010. Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit. Diagnostic Microbiology and Infectious Disease 68, 220-227.
6. de Llanos R., Querol A., Planes A.M., Fernández-Espinar M.T. Molecular characterisation of clinical Saccharomyces cerevisiae isolates and their association with non-clinical strains. Systematic and Applied Microbiology 2004, 27:427-435.
7. de Llanos R., Querol A., Pemán J., Gobernado M., Fernández-Espinar M.T. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. International Journal of Food Microbiology 2006, 110:286-290.
8. de Llanos R., Fernandez-Espinar M.T., Querol A. A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors. Antonie van Leeuwenhoek 2006, 90:221-231.
9. Deak T., Beuchat L. Handbook of spoilage yeasts 1996, CRC, Boca Raton.
10. Enache-Angoulvant A., Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clinical Infectious Diseases 2005, 41:1559-1568.
11. Fernández-Espinar M.T., López V., Ramón D., Bartra E., Querol A. Study of the authenticity of commercial wine yeast strains by molecular techniques. International Journal of Food Microbiology 2001, 70:1-10.
12. Fleet G.H., Balia R. The public health and probiotic significance of yeasts in foods and beverages. Yeasts in food and beverages 2006, 13-53. Springer-Verlag, Heidelberg. A. Querol, G. Fleet (Eds.).
13. Fröhlich-Wyder M.T. Yeasts in dairy products. Yeasts in Food. Beneficial and Detrimental Aspects 2003, 209-237. Behr, Hamburg. T. Boekhout, V. Robert (Eds.).
14. Hazen K.C. New and emerging yeast pathogens. Clinical Microbiology Reviews 1995, 8:462-478.
15. Herbrecht R., Nivoix Y. Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clinical Infectious Diseases 2005, 40:1635-1637.
16. Jacques N., Casaregola S. Safety assessment of dairy microorganisms: the hemiascomycetous yeasts. International Journal of Food Microbiology 2008, 126:321-326.
17. Jensen D.P., David M.D., Smith M.D. Fever of unknown origin secondary to brewer's yeast ingestion. Archives of Internal Medicine 1976, 136:332-333.
18. Klingberg T.D., Lesnik U., Arneborg N., Raspor P., Jespersen L. Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulent traits. FEMS Yeast Research 2008, 8:631-640.
19. Lherm T., Monet C., Nougiere B., Soulier M., Larbi D., Le Gall C., Caen D., Malbrunot C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Medicine 2002, 28:797-801.
20. Lolis N., Veldekis D., Moraitou H., Kanavaki S., Velegraki A., Triandafyllidis C., Tasioudis C., Pefanis A., Pneumatikos I. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Critical Care 2008, 12:414.
21. Loureiro V., Malfeito-Ferreira M. Spoilage yeasts in the wine industry. International Journal of Food Microbiology 2003, 86:23-50.
22. Loureiro V., Querol A. The prevalence and control of spoilage yeasts in foods and beverages. Trends in Food Science and Technology 1999, 10:356-365.
23. MacCallum D.M., Odds F.C. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 2004, 48:141-161.
24. MacKenzie D.A., Defernez M., Dunn W.B., Brown M., Fuller L.J., de Herrera S.R., Günther A., James S.A., Eagles J., Philo M., Goodacre R., Roberts I.N. Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics. Yeast 2008, 25:501-512.
25. McCullough M.J., Clemons K.V., McCusker J.H., Stevens A.D. Species identification and virulence attributes of Saccharomyces boulardii (nom. Inval.). Journal of Clinical Microbiology 1998, 36:2613-2617.
26. McCusker J.H., Clemos K.V., Stevens D.A., Davis R.W. Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42°C and form pseudohyphae. Infection and Immunity 1994, 62:5447-5455.
27. Montineri A., Lacobello C., Larocca L., La Rosa R., Nigro L., Fatuzzo F. Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis. Le Infezioni in Medicina 2008, 16:227-229.
28. Muñoz P., Bouza E., Cuenca-Estrella M., Eiros J.M., Perez M.J., Sanchez-Somolinos M., Rincon C., Hortal J., Pelaez T. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clinical Infectious Diseases 2005, 40:1625-1634.
29. Murphy A., Kavanagh K. Emergence of Saccharomyces cerevisiae as a human pathogen. Implications for biotechnology. Enzyme and Microbial Technology 1999, 25:551-557. Review.
30. Okawa Y., Yamada Y. Lethality of yeasts with low pathogenicity in mice immunocompromised by cyclophosphamide treatment. Biological and Pharmaceutical Bulletin 2002, 25:940-942.
31. Pontón J., Rüchel R., Clemons K.V., Coleman D.C., Grillot R., Guarro J., Aldebert D., Ambroise-Thomas P., Cano J., Carrillo-Muñoz A.J., Gené J., Pinel C., Stevens D.A., Sullivan D.J. Emerging pathogens. Medical Mycology 2000, 38:225-236.
32. Posteraro B., Sanguinetti M., D'Amore G., Masucci L., Morace G., Fadda G. Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. Journal of Clinical Microbiology 1999, 37:2230-2235.
33. Querol A., Barrio E., Ramón D. A comparative study of different methods of yeast strain characterisation. Systematic and Applied Microbiology 1992, 15:439-446.
34. Romano P., Capece A., Jespersen L. Taxonomic and ecological diversity of food and beverage yeasts. Yeasts in food and beverages 2006, 13-53. Springer-Verlag, Heidelberg. A. Querol, G. Fleet (Eds.).
35. Smith D., Metzgar D., Wills C., Fierer J. Fatal Saccharomyces cerevisiae aortic graft infection. Journal of Clinical Microbiology 2002, 40:2691-2692.
36. Sobel J.D., Schmitt C.A., Lynch M., Vazquez J., Zervos M. Emerging problem of vaginitis due to Saccharomyces cerevisiae. Clinical Infectious Diseases 1993, 16:93-94.
37. Swinne D., Nolard N.Van, Rooij P., Detandt M. Bloodstream yeast infections: a 15-month survey. Epidemiology and Infection 2009, 137:1037-1040.
38. Tudor E., Board R. Food spoilage yeasts. The yeasts 1993, vol. 5:435-516. Academic, London. Second ed. A.H. Rose, J.S. Harrison (Eds.).
39. Wheeler R.T., Kupiec M., Magnelli P., Abeijon C., Fink G.R. A Saccharomyces cerevisiae mutant with increased virulence. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2766-2770.
40. Williams J.S., Mufti G.J., Powell S., Salisbury J.R., Higgins E.M. Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia. Clinical and Experimental Dermatology 2007, 32:395-397.
41. Yáñez A., Murciano C., Llopis S., Fernández-Espinar M.T., Gil M.L., Gozalbo D. In vitro and in vivo studies on virulence and host responses to Saccharomyces cerevisiae clinical and non-clinical isolates. The Open Mycology Journal 2009, 3:37-47.
42. Zuluaga A.F., Salazar B.E., Rodriguez C.A., Zapata A.X., Agudelo M., Vesga O. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infectious Diseases 2006, 6:55.